Fresenius Medical Care AG & Co. (FMS) reported third-quarter 2024 adjusted earnings per share (EPS) of 45 cents, which surpassed the Zacks Consensus Estimate by 7.1%. The bottom line improved 45.2% year over year.During the reported quarter, the company’s closed divestments included clinic operations in Curacao, Guatemala and Peru.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Revenue DetailRevenues of $5.23 billion (EUR 4,760 million) missed the Zacks Consensus Estimate by 2.4%. T ...